Objectives: The aim of this study was to report a small series of fine-needle aspiration (FNA) cytology of the plasmacytoid variant of urothelial carcinoma (PVUC). Study Design: A computerized search of our laboratory information system was performed for the 5-year period between January 2008 and January 2013 to identify all FNA cases in which the corresponding surgical pathology cases were diagnosed as PVUC. Results: The 4 cases identified were from 2 men (aged 56 and 64 years) and 2 women (aged 72 and 46 years). The FNA smears demonstrated low-to-moderate cellularity and consisted predominantly of single and dyshesive, medium-sized tumor cells with eccentrically located nuclei and a moderate-to-abundant dense cytoplasm. The nuclei were oval with slightly irregular nuclear membranes and contained coarse granular chromatin with inconspicuous or small nucleoli. There was moderate nuclear variation in size. The nuclear-to-cytoplasmic ratio ranged from <1 to 3. Binucleation, cytoplasmic vacuoles, and perinuclear hof were occasionally seen. Conclusions: FNA cytology of PVUC shares features with plasma cell neoplasms, lobular carcinoma of the breast, and signet ring cell carcinoma of the stomach. Being aware of the patient's clinical history and the potential diagnostic pitfall of this rare variant of urothelial carcinoma is important for an accurate diagnosis on FNA biopsy.

Keywords:
Fine-needle aspiration, Plasmacytoid urothelial carcinoma, Cytology
1.
Eble J, Sauter G, Epstein JI, Sesterhenn IA (eds): World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, IARC, 2004, pp 101-102.
2.
Nigwekar P, Tamboli P, Amin MB, Osunkoya AO, Ben-Dor D, Amin MB: Plasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases. Am J Surg Pathol 2009;33:417-424.
3.
Lopez-Beltran A, Requena MJ, Montironi R, Blanca A, Cheng L: Plasmacytoid urothelial carcinoma of the bladder. Hum Pathol 2009;40:1023-1028.
4.
Keck B, Stoehr R, Wach S, Rogler A, Hofstaedter F, Lehmann J, Montironi R, Sibonye M, Fritsche HM, Lopez-Beltran A, Epstein JI, Wullich B, Hartmann A: The plasmacytoid carcinoma of the bladder-rare variant of aggressive urothelial carcinoma. Int J Cancer 2011;129:346-354.
5.
Molek KR, Seili-Bekafigo I, Štemberger C, Jonjić N, Đordević G, Duletić-Načinović A: Plasmacytoid urothelial carcinoma - diagnostic challenge in cytology. Diagn Cytopathol 2013;41:369-373.
6.
Lau SK: Cytomorphologic features of the plasmacytoid variant of urothelial carcinoma: a case report. Diagn Cytopathol 2009;37:359-364.
7.
Zhang XM, Elhosseiny A, Melamed MR: Plasmacytoid urothelial carcinoma of the bladder: a case report and the first description of urinary cytology. Acta Cytol 2002;46:412-416.
8.
Sakuma T, Furuta M, Mimura A, Tanigawa N, Takamizu R, Kawano K: Urine cytological findings of plasmacytoid urothelial carcinoma of urinary bladder: report of two cases. Cytopathology 2009;20:264-267.
9.
Sahin AA, Myhre M, Ro JY, Sneige N, Dekmezian RH, Ayala AG: Plasmacytoid transitional cell carcinoma: report of a case with initial presentation mimicking multiple myeloma. Acta Cytol 1991;35:277-280.
10.
Olsen DL, Anderson SR: Metastatic plasmacytoid urothelial carcinoma: a case report and review of the literature. Acta Cytol 2014;58:108-112.
11.
Kaimakliotis HZ, Monn MF, Cary KC, Pedrosa JA, Rice K, Masterson TA, Gardner TA, Hahn NM, Foster RS, Bihrle R, Cheng L, Koch MO: Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm? Urol Oncol 2014;32:833-838.
12.
Cantley RL, Kapur U, Truong L, Cimbaluk D, Barkan GA, Wojcik E, Gattuso P: Fine-needle aspiration diagnosis of metastatic urothelial carcinoma: a review. Diagn Cytopathol 2012;40:173-178.
13.
Powers CN, Elbadawi A: ‘Cercariform' cells: a clue to the cytologic diagnosis of transitional cell origin of metastatic neoplasms? Diagn Cytopathol 1995;13:15-21.
14.
Kao CS, Idrees MT, Cheng L, Grignon DJ: The immunohistochemical profile of the plasmacytoid variant of urothelial carcinoma: a study of 11 cases (abstract 903). Mod Pathol 2012;25(suppl 2):216A.
15.
Demirovic A, Marusic Z, Lenicek T, Spajic B, Balicevic D, Tomas D, Kruslin B: CD138-positive plasmacytoid urothelial carcinoma of urinary bladder with focal micropapillary features. Tumori 2010;96:358-360.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.